Sunshine Guojian Pharmaceutical Hits Day High with 6.73% Surge

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has shown significant momentum today, achieving a notable intraday high of CNY 53.82, reflecting a robust increase of 6.73% on June 30, 2026. This performance stands in stark contrast to the China Shanghai Composite, which only rose by 0.5% on the same day. Over the past week, Sunshine Guojian has surged by 17.4%, and its one-month performance is equally impressive at 19.48%. Year-to-date, the stock has climbed 29.25%, significantly outperforming the broader market's 3.16% gain. Over the last year, the stock has delivered a remarkable return of 41.95%, compared to the China Shanghai Composite's 18.87%. The company has consistently reported positive results for the last ten consecutive quarters, with operating cash flow reaching a high of CNY 2,979.1 million. Its return on equity stands at 33.75%, and the stock maintains a price-to-book ratio of 3.83. With a market capitalization of CNY 32,998 million, Sunshine Guojian continues to solidify its position in the pharmaceuticals and biotechnology sector.